Solitron Devices director sells 8,000 shares
Solitron Devices Inc. director John F. Chiste reported a sale of 8,000 shares of common stock on 2026-08-14 at $28.50 per share in a private agreement with Allens Creek Partners LP.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Solitron Devices Inc. director John F. Chiste reported a sale of 8,000 shares of common stock on 2026-08-14 at $28.50 per share in a private agreement with Allens Creek Partners LP. The transaction reduced his directly held common stock position to zero shares, and the shares retain an affiliate restriction after the sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common stock F1 | 8,000 | $28.50 | $228K |
Footnotes (1)
- F1. Mr. Chiste sold these shares through a private agreement with Allens Creek Partners LP. The sale price was agreed to prior to the sale date and subsequent price change. Eriksen Capital Management LLC ("ECM"), managed by Tim Eriksen, Solitron's CEO, has a sub-advisory agreement with Allens Creek. Shares retain an affiliate restriction after the sale.
Key Figures
Key Terms
affiliate restriction regulatory
sub-advisory agreement financial
private agreement financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Solitron Devices (SODI) disclose for John F. Chiste?
What does the Form 4 footnote reveal about Allens Creek Partners LP and Solitron Devices (SODI)?
Was John F. Chiste’s Solitron Devices (SODI) sale under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.